ECO Animal Health is a leading global animal health company developing and marketing branded veterinary products that optimise livestock wellbeing and productivity.
Our commitment to our customers is to provide them with products of a consistently high quality supported by customer-focused teams.
To deliver innovative animal health products that optimise livestock wellbeing and productivity.
To drive the next generation of veterinary innovation for disease management, animal welfare and sustainable food production.
Our Values fall under the ‘3 C’s’ of: Collaboration, Commitment and Curiosity.
ECO is also collaborating with research institutions on the development of a unique vaccine based on innovative technologies for Marek’s disease virus (MDV), infectious bursal disease virus (IBDV), Newcastle disease virus (NDV) and infectious laryngotracheitis virus (ILTV) and on the development of a novel biopharmaceutical approach for the control of infectious bronchitis virus (IBV).
ECO has an ongoing collaboration to develop novel vaccine approaches to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).
Since veterinary surgeons will continue to require effective antibiotics, a unique, long-acting, injectable animal-only antibiotic (florfenicol), intended for use in pigs and by veterinary prescription, is in our pipeline. ECO’s long-acting Florfenicol antibiotic is in late-stage development and an example of our commitment to veterinary only medications.
